Toshimitsu Fujii

13PUBLICATIONS
33CO-AUTHORS
Immunogenetics (incl. genetic immunology)AutoimmunityPredictive and prognostic markersClinical pharmacology and therapeuticsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 15, 2025
Real-World Effectiveness and Safety of Vedolizumab in Patients ≥ 70 Versus < 70 Years With Ulcerative Colitis: Multicenter Retrospective Study.

Tadakazu Hisamatsu, Taku Kobayashi, Satoshi Motoya

|Nov 23, 2024
Comparative Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis: A Real-World Multicentre Study in Japan.

Shintaro Akiyama, Hiromichi Shimizu, Akiko Tamura

|Mar 18, 2024
Efficacy and safety of filgotinib for ulcerative colitis: A real-world multicenter retrospective study in Japan.

Shintaro Akiyama, Kaoru Yokoyama, Soichi Yagi

|Nov 14, 2023
COVID-19 severity is associated with the risk of gastrointestinal bleeding.

Shuji Hibiya, Takashi Fujii, Toshimitsu Fujii

Pageof 3